TABLE 3.
IV iron treatment
| Trade name | INFeD-US CosmoFer | Feraheme | Injectafer, US Ferinject | Monofer-Europe only | Venofer | Ferrlecit |
|---|---|---|---|---|---|---|
| Generic name | LMW iron dextran | Ferumoxytol | Ferric carboxymaltose | Iron isomaltoside | Iron sucrose | Sodium ferric gluconate |
| Manufacturer | Allergan/Watson Pharma | AMAG Pharmaceuticals | Vifor Pharma | Pharmacosmos | American Regent Inc | Sanofi Aventis Inc |
| Carbohydrate | Low-molecular-weight iron dextran | Ferumoxytol | Carboxymaltose | Isomaltoside | Sucrose | Gluconate |
| Total dose infusion | Yes | No | Yes | Yes | No | No |
| Test dose required | Yes | No | No | No | No | No |
| Approved dose | 100 mg per dose | 510 mg over 15 min | 750 mg over 15 min | 20 mg/kg (1000 mg if >66 kg) | ||
| Recommended dose | 1000 mg | 510 mg × 2 | 750 mg × 2 | 1000 mg | 200–300 mg | 125–187.5 mg |
| Infusion time | 1 h | 15 min | 15 min | 15 min | 15 min | 1 h |
| Black box warning | Yes | Yes | Yes | NA | No | No |
| Pregnancy category | C | C | C | Not listed | B | B |